By Bill Fisher | October 21st, 2020
The nice thing about these kinds of algorithms is that they’re not limited to just one specific bit of information. The algorithms take a composite picture of what the short-term change in brain anatomy looks like based on an MRI, or knowing if someone has certain copies of ApoE, and assess whether that makes their risk worse. Also, knowing that this is their brain signature and this is what their cognitive data looked like, does that make a difference at all? I think all those things together is what we’re trying to look at. We’re targeting anyone who is elderly and thinks they may have a risk.
